The Current Ratio as of December 2025 (TTM) for Telomir Pharmaceuticals, Inc. Common Stock (TELO) is 17.51

According to Telomir Pharmaceuticals, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 17.51. This represents a change of 210.06% compared to the average of 5.65 of the last 4 quarters.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) Historical Current Ratio (quarterly & annually)

How has TELO Current Ratio performed in the past?

The mean historical Current Ratio of Telomir Pharmaceuticals, Inc. Common Stock over the last ten years is 0.58. The current 17.51 Current Ratio has changed 301.80% with respect to the historical average. Over the past ten years (40 quarters), TELO's Current Ratio was at its highest in in the September 2025 quarter at 17.51. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Telomir Pharmaceuticals, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) Average Current Ratio

How has TELO Current Ratio performed in the past?

The current Current Ratio of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Telomir Pharmaceuticals, Inc. Common Stock (TELO) Current Ratio vs. Peers

How is TELO’s Current Ratio compared to its peers?

Telomir Pharmaceuticals, Inc. Common Stock’s Current Ratio is greater than Medicus Pharma Ltd. Common Stock (0.92), greater than Genenta Science S.p.A. (13.20), greater than Century Therapeutics, Inc. (10.72), greater than Barinthus Biotherapeutics plc (8.04), greater than CEL-SCI Corporation (0.47), greater than Karyopharm Therapeutics Inc. (1.03), greater than Skye Bioscience, Inc. (6.09), greater than Coeptis Therapeutics, Inc. (2.21), greater than Equillium, Inc. (10.85), greater than INmune Bio, Inc. (4.17),

Build a custom stock screener for Telomir Pharmaceuticals, Inc. Common Stock (TELO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telomir Pharmaceuticals, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Telomir Pharmaceuticals, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.